Jump to content
Powered by

EuroTransBio – Transnational R&D&I Cooperation of Biotech SMEs

Type
Funding programme
Funded by
EuroTransBio

EuroTransBio (ETB) is an international funding initiative supported by European program owners. It has established itself as the preferred funding instrument for small and medium sized enterprises (SMEs), collaborating in the area of modern biotechnology.

Since 2006, ETB has been launching annual calls for innovative research proposals. ETB operates under the ERA-NET scheme since 2004 and will develop to an international funding initiative in 2013. Also in the future, ETB will continue to launch annual calls.

The mission of ETB is to foster the competitiveness of the European biotechnology industry by supporting research intensive SMEs and their strategic partner with the aim of achieving a thriving European biotechnology industry.

The 13th transnational call for proposals is open from October 4th, 2017

Deadline for proposals submission will be January 31st, 2018, 3 PM CET.

The following countries / regions participate in the 13th ETB Call:

Austria, Flanders (Belgium), Finland, Alsace, Lorraine, Champagne-Ardenne (France), Germany and Russia.

SMEs, large enterprises and research organizations can apply for funding (national/regional rules may apply).

Consortia must be coordinated by an SME and include at least two com- panies from two different countries participating in ETB. They may include additional partners from research organizations. A minimum of 50% of the total project costs must be allocated to SMEs. All project partners should contribute to, and benefit from, an equitable and balanced cooperation (maximum 70% of the budget to partners from the same country).

Applicants from countries/regions not represented in ETB and SMEs from outside Europe (e.g. US companies) are welcome to participate in ETB projects but must cover their own research expenses (no funding).

Website address: https://www.gesundheitsindustrie-bw.de/en/database/funding/eurotransbio-transnational-rdi-cooperation-of-biotech-smes